Gemcitabine associated vasculitis leading to necrotizing enterocolitis and death in women undergoing primary treatment for epithelial ovarian/peritoneal cancer.

Gynecol Oncol

Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Holden Comprehensive Cancer Center, University of Iowa Hospitals and Clinics, Iowa City, IO 52242, USA.

Published: February 2004

AI Article Synopsis

Article Abstract

We present two patients who developed necrotizing enterocolitis following their first cycle of chemotherapy for epithelial ovarian/peritoneal cancer. After optimal cytoreductive surgery, both women received gemcitabine as part of a chemotherapy protocol. One patient developed necrotizing enterocolitis, 1 day after chemotherapy and the other 8 days after chemotherapy. The first patient succumbed to the enterocolitis despite aggressive supportive care. The second patient succumbed despite both aggressive supportive care and surgical intervention. Pathologic review for both patients revealed a drug induced vasculitis causing necrotizing enterocolitis.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2003.10.050DOI Listing

Publication Analysis

Top Keywords

necrotizing enterocolitis
16
epithelial ovarian/peritoneal
8
ovarian/peritoneal cancer
8
developed necrotizing
8
patient succumbed
8
despite aggressive
8
aggressive supportive
8
supportive care
8
enterocolitis
5
gemcitabine associated
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!